1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Neurological Biomarkers Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Neurological Biomarkers Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Neurological Biomarkers Market Regional Analysis
6.2 North America Neurological Biomarkers Market Revenue 2017-2027 (US$ Million)
6.3 North America Neurological Biomarkers Market Forecast Analysis
7. North America Neurological Biomarkers Market Analysis – by Product
7.1 Proteomics Biomarker
- 7.1.1 Overview
- 7.1.2 Proteomics Biomarker: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Genomics Biomarker
- 7.2.1 Overview
- 7.2.2 Genomics Biomarker: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Metabolomics Biomarker
- 7.3.1 Overview
- 7.3.2 Metabolomics Biomarker: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Imaging Biomarker
- 7.4.1 Overview
- 7.4.2 Imaging Biomarker: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Neurological Biomarkers Market Analysis – by Application
8.1 Alzheimer's Disease
- 8.1.1 Overview
- 8.1.2 Alzheimer's Disease: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Parkinson's Disease
- 8.2.1 Overview
- 8.2.2 Parkinson's Disease: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Schizophrenia
- 8.3.1 Overview
- 8.3.2 Schizophrenia: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Huntington's Disease
- 8.4.1 Overview
- 8.4.2 Huntington's Disease: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Spinal Muscular Atrophy
- 8.5.1 Overview
- 8.5.2 Spinal Muscular Atrophy: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Neurological Biomarkers Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Pharmaceutical and Biotechnology Companies: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Clinical Diagnostics
- 9.2.1 Overview
- 9.2.2 Clinical Diagnostics: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Research Organizations
- 9.3.1 Overview
- 9.3.2 Research Organizations: North America Neurological Biomarkers Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Neurological Biomarkers Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Neurological Biomarkers Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Neurological Biomarkers Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Neurological Biomarkers Market Breakdown, by Product
- 10.2.1.1.2 US: North America Neurological Biomarkers Market Breakdown, by Application
- 10.2.1.1.3 US: North America Neurological Biomarkers Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Neurological Biomarkers Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Neurological Biomarkers Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Neurological Biomarkers Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Neurological Biomarkers Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Neurological Biomarkers Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Neurological Biomarkers Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Thermo Fisher Scientific, Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bio-Rad Laboratories Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Banyan Biomarkers
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Abbott
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Quest Diagnostics Incorporated
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Perkin Elmer, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Neurological Biomarkers Market
